These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34155028)

  • 1. Acquired haemophilia A: successful treatment of a patient using upfront immunosuppressive therapy and haemostatic agents.
    Chung SY; Shen JG; Sticco KL
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34155028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry.
    Tengborn L; Baudo F; Huth-Kühne A; Knoebl P; Lévesque H; Marco P; Pellegrini F; Nemes L; Collins P;
    BJOG; 2012 Nov; 119(12):1529-37. PubMed ID: 22901076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of acquired haemophilia A in severe Covid-19: Haemostatic bridging with emicizumab to keep the balance between bleeding and thrombosis.
    Gelbenegger G; Traby L; Rahimi N; Knöbl P
    Br J Clin Pharmacol; 2023 Feb; 89(2):908-913. PubMed ID: 36369653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of the unique bleeding pattern and laboratory findings in acquired haemophilia A facilitates prompt treatment of a life-threatening disorder.
    Cameron H; Perez Botero J
    BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34344656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of CARE: a 6-year national registry of acquired haemophilia A in China.
    Sun B; Xue F; Feng Y; Sun J; Yu Z; Hou M; Zhang J; Zeng X; Zhao Y; Lian S; Huang M; Niu T; Cui Z; Wu J; Yang R
    Br J Haematol; 2019 Dec; 187(5):653-665. PubMed ID: 31372978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emicizumab for the treatment of acquired hemophilia A: Retrospective review of a single-institution experience.
    Chen EC; Gibson W; Temoczko P; Connell NT; Handin R; Parnes AD
    Haemophilia; 2023 Jan; 29(1):84-89. PubMed ID: 36163651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying risk factors and optimizing standard of care for patients with acquired haemophilia A: Results from a Czech patient cohort.
    Salaj P; Geierová V; Ivanová E; Loužil J; Pohlreichová V; Hrachovinová I; Dulíček P
    Haemophilia; 2020 Jul; 26(4):643-651. PubMed ID: 32590889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemostatic therapy as a management strategy for acquired hemophilia: what does the future hold?
    Franchini M; Schiavulli M; Liumbruno GM
    Expert Rev Hematol; 2021 Mar; 14(3):263-270. PubMed ID: 33655810
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcome of acquired haemophilia in France: the prospective SACHA (Surveillance des Auto antiCorps au cours de l'Hémophilie Acquise) registry.
    Borg JY; Guillet B; Le Cam-Duchez V; Goudemand J; Lévesque H;
    Haemophilia; 2013 Jul; 19(4):564-70. PubMed ID: 23574453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A low-dose rituximab regimen for first-line treatment of acquired haemophilia A.
    Hunt S; Robertson J; Conn J; Casey J; Royle J; Collins J; Hourigan M; Richmond J; Yang Wang T; Mills A; Mason J
    Eur J Haematol; 2022 Jan; 108(1):28-33. PubMed ID: 34528303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired haemophilia A associated with autoimmune thyroiditis: a case report.
    Pathirana UG; Gunawardena N; Abeysinghe H; Copley HC; Somarathne MG
    J Med Case Rep; 2014 Dec; 8():469. PubMed ID: 25547669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).
    Knoebl P; Marco P; Baudo F; Collins P; Huth-Kühne A; Nemes L; Pellegrini F; Tengborn L; Lévesque H;
    J Thromb Haemost; 2012 Apr; 10(4):622-31. PubMed ID: 22321904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired haemophilia: an overview for clinical practice.
    Kessler CM; Knöbl P
    Eur J Haematol; 2015 Dec; 95 Suppl 81():36-44. PubMed ID: 26679396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-label use of emicizumab in persons with acquired haemophilia A and von Willebrand disease: A scoping review of the literature.
    Thomas VM; Abou-Ismail MY; Lim MY
    Haemophilia; 2022 Jan; 28(1):4-17. PubMed ID: 34820989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired Haemophilia A Associated with Subsequent Hepatocellular Carcinoma.
    Pacholczak R; Bazan-Socha S; Zdziarska J; Iwaniec T; Walocha JA; Musiał J; Dropiński J
    Hamostaseologie; 2019 Feb; 39(1):95-99. PubMed ID: 30112740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired haemophilia and haemostatic control with recombinant porcine factor VIII: case series.
    Campbell S; Mason J; Prasad R; Ambrose H; Hunt S; Tran H
    Intern Med J; 2021 Feb; 51(2):215-219. PubMed ID: 32043744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired hemophilia A: a review of recent data and new therapeutic options.
    Franchini M; Vaglio S; Marano G; Mengoli C; Gentili S; Pupella S; Liumbruno GM
    Hematology; 2017 Oct; 22(9):514-520. PubMed ID: 28441921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Therapy In Acquired Haemophilia - A Single Institute Experience.
    Sarah L; Prantik D; Gary B
    Ulster Med J; 2016 Sep; 85(3):187-192. PubMed ID: 27698522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emicizumab in acquired haemophilia A: about two clinical cases and literature review.
    Hansenne A; Hermans C
    Ther Adv Hematol; 2021; 12():20406207211038193. PubMed ID: 34471508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and open issues in the management of acquired hemophilia A (AHA).
    Shetty SD; Ghosh K
    Blood Cells Mol Dis; 2015 Mar; 54(3):275-80. PubMed ID: 25486929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.